OXAPROZIN DOSE PROPORTIONALITY

被引：11

作者：

CHIANG, ST

LASSETER, KC

FLUCK, ER

JANSSEN, FW

LEELAVATHI, D

HUBSHER, JA

机构：

[1] UNIV MIAMI,SCH MED,MIAMI,FL 33152

[2] CLIN PHARMACOL ASSOCIATES,MIAMI,FL

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 24卷 / 11-1期

关键词：

D O I：

10.1002/j.1552-4604.1984.tb02761.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：515 / 522

页数：8

共 29 条

[1] CLINICAL PHARMACOKINETICS OF PHENYLBUTAZONE [J].

AARBAKKE, J .

CLINICAL PHARMACOKINETICS, 1978, 3 (05) :369-380

[2]

BONO R F, 1983, Clinical Therapeutics, V6, P79

[3] DIARYLOXAZOLE AND DIARYLTHIAZOLEALKANOIC ACIDS - 2 NOVEL SERIES OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS [J].

BROWN, K ;

CAVALLA, JF ;

GREEN, D ;

WILSON, AB .

NATURE, 1968, 219 (5150) :164-&

[4] SHAM, A METHOD FOR BIEXPONENTIAL CURVE RESOLUTION USING INITIAL SLOPE, HEIGHT, AREA AND MOMENT OF EXPERIMENTAL DECAY TYPE CURVE [J].

CAPRANI, O ;

SVEINSDOTTIR, E ;

LASSEN, N .

JOURNAL OF THEORETICAL BIOLOGY, 1975, 52 (02) :299-315

[5] SERUM CONCENTRATIONS OF FLURBIPROFEN IN RHEUMATOID PATIENTS RECEIVING FLURBIPROFEN OVER LONG PERIODS OF TIME [J].

CARDOE, N ;

SILVA, MD ;

GLASS, RC ;

RISDALL, PC .

CURRENT MEDICAL RESEARCH AND OPINION, 1977, 5 (01) :21-31

[6] OXAPROZIN DISPOSITION IN RENAL-DISEASE [J].

CHIANG, ST ;

MORRISON, G ;

KNOWLES, JA ;

RUELIUS, HW ;

WALKER, BR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :509-515

[7]

DAVIS LF, 1983, DEC AM SOC HOSP PHAR

[8] CONCENTRATION DEPENDENT PLASMA-PROTEIN BINDING OF SALICYLATE IN RHEUMATOID PATIENTS [J].

EKSTRAND, R ;

ALVAN, G ;

BORGA, O .

CLINICAL PHARMACOKINETICS, 1979, 4 (02) :137-143

[9] FACTORS AFFECTING DRUG METABOLISM [J].

GILLETTE, JR .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :43-&

[10]

HENSON R, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P217

← 1 2 3 →